Close Menu


News items for the week of Feb. 1, 2021. 

The expert body now recognizes the test's ability to predict whether early-stage breast cancer patients will benefit from extended, adjuvant endocrine therapy.

News items for the week of Jan. 4, 2021. 

Hologic said that Biotheranostics' PCR-based gene expression tests have been validated in large studies in areas of oncology with high growth potential.